Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Barrett

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
NIHR Open Research|February 19, 2026
Development of a Cystic Fibrosis Weight Management Programme:  protocol for a co-design studyJoanne Barrett, Anne Elizabeth Topping, Nikos Ntoumanis, et al.
The Open Respiratory Medicine Journal|March 6, 2015
Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the communityHeena Khiroya, Rebecca Pound, Ushna Qureshi, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarkerLucy Lee, Huifeng Niu, Ruediger Rueger, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
NIHR Open Research|February 19, 2026
Development of a Cystic Fibrosis Weight Management Programme:  protocol for a co-design studyJoanne Barrett, Anne Elizabeth Topping, Nikos Ntoumanis, et al.
The Open Respiratory Medicine Journal|March 6, 2015
Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the communityHeena Khiroya, Rebecca Pound, Ushna Qureshi, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarkerLucy Lee, Huifeng Niu, Ruediger Rueger, et al.
Pageof 2